Australian Clinical Labs Sees Change in Shareholder Interests
Company Announcements

Australian Clinical Labs Sees Change in Shareholder Interests

Australian Clinical Labs Ltd (AU:ACL) has released an update.

Australian Clinical Labs Ltd has seen a change in its substantial shareholder interests, with Australian Ethical Investment Limited reducing its voting power from 9.31% to 8.31% as of October 30, 2024. This adjustment in shareholding may influence investor sentiment and market dynamics surrounding the company’s stock.

For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App